DepoMed, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DepoMed with three other
companies in this sector in the United States:
sales of $420.43 million
Emergent BioSolutions, Inc.
of which 100%
was Human Health).
During the year ended December of 2016, sales at
DepoMed were $455.90 million.
increase of 33.0%
versus 2015, when the company's sales were $342.74 million.